The isolation of a novel Jiangella strain reported from a marine, animal-associated plastisphere is described and its biosynthetic repertoire is placed in the context of the whole genus, providing a genome-based prioritization of candidate biosynthetic targets.
Abstract
Rare actinobacteria are promising sources of specialized metabolites, yet genome mining still prioritizes genomes encoding many biosynthetic gene clusters (BGCs) rather than clusters that are distant from characterized chemistry. Here, we describe the isolation of a novel Jiangella strain reported from a marine, animal-associated plastisphere and place its biosynthetic repertoire in the context of the whole genus, providing a genome-based prioritization of candidate biosynthetic targets. Digital DNA-DNA hybridization (57.8%) and OrthoANIu (94.65%) values against its closest relative, J. alba DSM 45237ᵀ, support its assignment as a candidate novel species, although formal species description will require additional phenotypic and chemotaxonomic characterization. antiSMASH predicted twelve BGCs, within the range observed across the genus (7–13), of which only one matched a characterized pathway, and the Biosynthetic Novelty Index of the genome was 865.3, the fourth highest among the twelve genomes analyzed. Across these genomes, 124 BGCs grouped into 70 gene cluster families, 74% of them strain-specific. Two families without any characterized representative, a lasso-peptide family and a RiPP recognition element-containing family, were instead conserved across a subclade, down to nearly identical precursor peptides. No antimicrobial activity was detected under the conditions tested. Genus-wide comparison therefore identifies conserved yet uncharacterized families as rational priorities that cluster counts alone would miss.
The effectiveness of integrated genome-mining strategies for prioritizing cryptic biosynthetic gene clusters is demonstrated and the remarkable biosynthetic potential of newly identified Streptomyces isolates as a source of novel natural products is highlighted.
Nada S. Al-Theyab, Haila M. Alnassar, Mohanad A. Ibrahim et al.· Frontiers in Microbiology· 0 citations
Siderochelin A, a monomeric compound isolated from a fermentation product, demonstrated antibacterial efficacy against various pathogenic bacteria, providing a theoretical basis for discovering novel species, exploring secondary metabolites, and developing innovative antibiotics.
Yi-Huang Chen, Lu Wang, Tao Luo et al.· Microorganisms· 0 citations
Comparative genomic and biosynthetic analyses of 24 Talaromyces species reveal extensive diversification alongside selective conservation of secondary-metabolite pathways across Talaromyces and provide a genomic framework for prioritizing species and BGCs for antifungal natural-product discovery and biocontrol-oriented...
B. Chellappan, Hashem Al-Sheikh· Journal of Fungi· 0 citations
The resulting framework prioritises reproducible candidates while reserving chemical identity, expression and ecological function for direct validation in basidiomycetes to obscure pathway-centred conservation in basidiomycetes.
Hui-Jun Su, Ming Luo, Yu-Huan Miao et al.· Journal of Fungi· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.